Skip to main navigation
  • LogicBio Therapeutics, Inc.

Investors

  • About
  • Platforms
    • GeneRide
    • Overview
    • Partnering
    • Publications
    • sAAVy
  • Pipeline
  • Patients & Families
    • About MMA
    • Patient Stories
    • Community Resources
    • Clinical Trials
  • Investors
    • Overview
    • Press Releases
    • Events and Presentations
    • Stock Information
    • Corporate Governance
    • Financial informations
    • Investor FAQs
    • Email Alerts
    • Contact IR
    • IR Search
  • Careers
  • Contact

Investors Menu

  • Overview
  • Press Releases
  • Events and Presentations
    • Event Calendar
    • Presentations
  • Stock Information
    • Stock Chart & Quote
    • Historic Price Lookup
    • Analyst Coverage
    • Investment Calculator
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Committee Composition
  • Financial information
    • SEC Filings
    • Annual reports and proxy materials
  • Investor FAQs
  • Email Alerts
  • Contact IR
  • IR Search

SEC Filing Details

SEC Filing Details

Document Details

Form
4
Filing Date
Apr 19, 2021
Document Date
Apr 15, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
LogicBio Therapeutics, Inc.
Issuer
LogicBio Therapeutics, Inc.
Filer
CHIANG KYLE

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
© 2022 LogicBio Therapeutics, Inc.
  • Privacy Policy
  • Contact